Celldex Therapeutics, Inc. (CLDX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$29.24
Day's range
$31.85

Celldex Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 9.54 M $355.12 M   11.49% 14.34%
BLACKROCK, INC. 08/07/2026 7.00 M $260.56 M   30.40% 10.52%
KYNAM CAPITAL MANAGEMENT, LP 08/14/2026 5.32 M $198.07 M   -8.86% 8.00%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 4.69 M $174.34 M   124.57% 7.04%
STATE STREET CORP 08/07/2026 3.90 M $145.13 M   39.09% 5.86%
FMR LLC 08/13/2026 3.72 M $138.53 M   -0.70% 5.59%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 3.46 M $128.93 M   17.02% 5.21%
DEEP TRACK CAPITAL, LP 08/14/2026 2.94 M $109.37 M   128.91% 4.42%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 2.10 M $78.14 M   366.67% 3.15%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 2.02 M $75.26 M   19.79% 3.04%
EVERSEPT PARTNERS, LP 08/14/2026 1.79 M $66.45 M   -0.12% 2.68%
GOLDMAN SACHS GROUP INC 08/14/2026 1.62 M $60.11 M   63.43% 2.43%
COMMODORE CAPITAL LP 08/14/2026 1.35 M $50.23 M   -49.94% 2.03%
BELLEVUE GROUP AG 08/14/2026 1.20 M $44.65 M   0.00% 1.80%
BAKER BROS. ADVISORS LP 08/14/2026 1.18 M $44.00 M   77.74% 1.78%
MILLENNIUM MANAGEMENT LLC 08/14/2026 1.17 M $43.56 M   -6.60% 1.76%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 1.07 M $39.96 M   1.36% 1.61%
AMERICAN CENTURY COMPANIES INC 08/12/2026 1.04 M $38.79 M   21.73% 1.57%
EVENTIDE ASSET MANAGEMENT, LLC 08/14/2026 1.04 M $38.59 M   0.00% 1.56%
NOVO HOLDINGS A/S 08/14/2026 1.03 M $38.14 M   -14.58% 1.54%
ELMIND CAPITAL, LP 08/14/2026 990.00 K $36.84 M   14.45% 1.49%
DRIEHAUS CAPITAL MANAGEMENT LLC 08/14/2026 989.44 K $36.82 M   100.00% 1.49%
FISHER ASSET MANAGEMENT, LLC 08/04/2026 985.68 K $36.68 M   -2.76% 1.48%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 917.41 K $34.14 M   -0.68% 1.38%
FORESITE CAPITAL MANAGEMENT VI LLC 08/14/2026 879.71 K $32.73 M   178.47% 1.32%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 863.54 K $32.13 M   37.23% 1.30%
ASSENAGON ASSET MANAGEMENT S.A. 08/21/2026 788.70 K $29.35 M   438.27% 1.18%
NORTHERN TRUST CORP 08/13/2026 719.65 K $26.78 M   24.66% 1.08%
WOODLINE PARTNERS LP 08/14/2026 700.83 K $26.08 M   40.13% 1.05%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 700.00 K $26.05 M   40.00% 1.05%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 699.15 K $26.02 M   7.52% 1.05%
TWO SIGMA INVESTMENTS, LP 08/14/2026 661.24 K $24.60 M   382.60% 0.99%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 655.95 K $24.41 M   20.25% 0.99%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 655.95 K $24.41 M   100.00% 0.99%
ALGERT GLOBAL LLC 08/13/2026 647.84 K $24.11 M   201.10% 0.97%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 619.54 K $23.05 M   44.82% 0.93%
BANK OF AMERICA CORP /DE/ 08/14/2026 607.20 K $22.59 M   -14.32% 0.91%
PANAGORA ASSET MANAGEMENT INC 08/06/2026 572.54 K $21.30 M   302.27% 0.86%
NUVEEN, LLC 08/11/2026 568.46 K $21.15 M   181.49% 0.85%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 552.97 K $20.58 M   28.72% 0.83%
5AM VENTURE MANAGEMENT, LLC 08/14/2026 497.27 K $18.50 M   0.00% 0.75%
FEDERATED HERMES, INC. 08/12/2026 492.89 K $18.34 M   100.00% 0.74%
UBS GROUP AG 08/13/2026 482.00 K $17.94 M   62.30% 0.72%
CANDRIAM S.C.A. 08/13/2026 481.13 K $17.89 M   72.52% 0.72%
IKARIAN CAPITAL, LLC 08/14/2026 478.50 K $17.80 M   3.74% 0.72%
BRAIDWELL LP 08/14/2026 436.65 K $16.25 M   -67.80% 0.66%
REDMILE GROUP, LLC 08/14/2026 433.92 K $16.15 M   65.93% 0.65%
CITIGROUP INC 08/03/2026 404.70 K $15.06 M   86.21% 0.61%
PALO ALTO INVESTORS LP 08/19/2026 399.86 K $14.88 M   34.90% 0.60%
TSP CAPITAL MANAGEMENT GROUP, LLC 07/31/2026 371.13 K $13.81 M   -1.07% 0.56%

Celldex Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 312 institutional investors and hedge funds held shares of Celldex Therapeutics Inc.. The most heavily invested institutionals were:

WELLINGTON MANAGEMENT GROUP LLP: 9.54 M

BlackRock, Inc.: 7 M

Kynam Capital Management, LP: 5.32 M

PRICE T ROWE ASSOCIATES INC /MD/: 4.69 M

STATE STREET CORP: 3.9 M

FMR LLC: 3.72 M

128.62% of Celldex Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 98.15 M shares in the last 24 months. This purchase volume represents approximately $3.02 B in transactions.